Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. (Q53127302)

11 May 2018

title

Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. (English)

1 reference

11 May 2018

author

Raoul Herbrecht

12

1 reference

11 May 2018

Valérie Letscher-Bru

9

object named as

Valérie Letscher-Bru

1 reference

11 May 2018

Yasmine Nivoix

1

object named as

Yasmine Nivoix

1 reference

11 May 2018

author name string

Anne Launoy

2

1 reference

11 May 2018

Philippe Lutun

3

1 reference

11 May 2018

Jean-Charles Moulin

4

1 reference

11 May 2018

Katy-Anna Phai Pang

5

1 reference

11 May 2018

Luc-Matthieu Fornecker

6

1 reference

11 May 2018

Michèle Wolf

7

1 reference

11 May 2018

Dominique Levêque

8

1 reference

11 May 2018

Laurence Beretz

10

1 reference

11 May 2018

Geneviève Ubeaud-Sequier

11

1 reference

11 May 2018

language of work or name

English

0 references

publication date

9 July 2012

1 reference

11 May 2018

Journal of Antimicrobial Chemotherapy

published in

1 reference

11 May 2018

volume

67

1 reference

11 May 2018

issue

10

1 reference

11 May 2018

page(s)

2506-2513

1 reference

11 May 2018

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Adequacy of new systemic antifungal agents prescriptions in a teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Clinical audit on the use of expensive systemic antifungals in the Besançon University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Beta-D-glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Early antifungal intervention strategies in ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Prophylaxis, empirical and preemptive treatment of invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Factors associated with overall and attributable mortality in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Candidaemia in a large teaching hospital: a clinical audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Invasive candidiasis in ICU: analysis of antifungal treatments in the French study AmarCand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Use of fluconazole in daily practice: still room for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS256

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS256

1 reference

11 May 2018

release_3qor2fjiqbfijav2jvpmksspce

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3qor2fjiqbfijav2jvpmksspce

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 May 2018